Safety

GLP-1 Medications Before Surgery: What You Need to Know

GLP-1 Companion · 8 min read

GLP-1 receptor agonists like Ozempic (semaglutide), Wegovy, Mounjaro (tirzepatide), and Zepbound are among the most effective medications available for weight management and blood sugar control. But if you are scheduled for surgery or a procedure requiring anesthesia, these medications require special planning. Failing to pause them at the right time can lead to a potentially serious complication called aspiration.

Why GLP-1 Medications Create Surgical Risk

One of the primary mechanisms of GLP-1 drugs is slowing gastric emptying — food and liquid move through your stomach more slowly than normal. In everyday life, this helps you feel fuller longer and reduces calorie intake. Before surgery, however, it becomes a safety concern.

When you go under general anesthesia or deep sedation, your airway reflexes are suppressed. If your stomach is not fully empty and you vomit or regurgitate, stomach contents can be inhaled into your lungs — a dangerous event called pulmonary aspiration. GLP-1-induced delayed gastric emptying means your stomach may not be empty even after the standard fasting window, creating this elevated risk.

When to Stop Your GLP-1 Medication Before Surgery

Guidelines vary slightly by medication and procedure type, but the most widely followed recommendations as of 2026 are:

• Weekly injectable GLP-1s (Ozempic, Wegovy, Mounjaro, Zepbound): Hold the dose for at least 1 week (one full dosing cycle) before the procedure.
• Daily injectable GLP-1s (Victoza, Saxenda): Skip the dose the day of the procedure.
• Oral semaglutide (Rybelsus): Skip the dose the morning of surgery, following your usual fasting instructions.
• For urgent or emergency surgery: inform the anesthesia team immediately that you take a GLP-1 medication so they can take extra precautions.

These are general guidelines. Your surgeon, anesthesiologist, or prescribing clinician may adjust them based on your individual health situation, the type of procedure, and how long you have been on the medication. Always defer to the team managing your care.

What Counts as a Procedure That Requires These Precautions

The precautions apply broadly to any procedure involving:

• General anesthesia (where you are fully unconscious)
• Deep sedation (such as for colonoscopy, endoscopy, or some dental procedures)
• Neuraxial anesthesia (spinal or epidural) when combined with sedation
• Moderate sedation for procedures like cardiac catheterization or certain imaging studies

Local anesthesia only — for example, a minor skin procedure done with a topical numbing agent while you remain fully awake — generally does not require stopping your GLP-1 medication. When in doubt, ask your anesthesiologist or proceduralist directly.

Signs of Retained Gastric Contents Your Team May Watch For

Even after the recommended hold period, some surgical teams perform additional precautions for patients who have been on GLP-1 medications. These may include:

• Extending the pre-operative fasting window beyond the standard 8 hours for solids
• Using a rapid sequence induction (RSI) technique to secure the airway quickly under anesthesia
• Performing a bedside ultrasound of the stomach before anesthesia to confirm it is empty
• Avoiding certain sedating medications that increase aspiration risk

What to Tell Your Surgical Team

Proactive communication is essential. At your pre-operative appointment or when scheduling your procedure, tell your team:

1. The exact name of your GLP-1 medication (Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Saxenda, etc.)
2. Your current dose and how long you have been taking it
3. When you last took your dose
4. Any symptoms of gastroparesis you have noticed (feeling full very quickly, nausea after small meals, food sitting heavily in your stomach)

Do not wait for the team to ask — mention it proactively. Many patients do not realize their weight loss or diabetes medication is relevant to anesthesia planning, and some clinical staff may not routinely ask about GLP-1s unless prompted.

Managing Your Weight and Blood Sugar During the Hold Period

For most elective procedures, holding a GLP-1 for one week is unlikely to cause significant setbacks in your weight loss or metabolic progress. You may notice:

• Return of appetite: some patients feel hungrier during the hold week. This is normal and temporary.
• Slight rise in blood sugar: for people using GLP-1s to manage diabetes, your prescriber may advise temporary adjustments to other diabetes medications during the hold.
• Slower digestion normalizing: ironically, the hold period means your stomach empties more normally — exactly what the surgical team needs.

You can typically restart your GLP-1 medication as soon as you are tolerating oral intake after surgery, unless your clinical team advises otherwise.

What About Procedures Without General Anesthesia

Many routine procedures — lab draws, imaging scans, minor outpatient procedures under local anesthesia, routine dental cleanings — do not require any pause in your GLP-1 medication. The aspiration risk is specifically tied to suppressed airway reflexes during sedation or general anesthesia. If you are awake and in control of your airway, the risk is not present.

After Surgery: Resuming Your GLP-1

There is no hard rule on when to restart your GLP-1 after surgery, but general principles include:

• Wait until you are eating and drinking normally without significant nausea or vomiting.
• For weekly injectables, simply resume at your next scheduled injection day once cleared.
• If your surgery affected your digestive system directly (gastric surgery, bowel resection), ask your surgeon specifically when and whether to restart.
• If you experienced any post-operative complications, get clearance from your team before restarting.

The Bottom Line

GLP-1 medications are safe and effective for long-term use, but they require advance planning around surgery and procedures involving sedation or general anesthesia. The key steps are simple: inform your entire surgical team that you take a GLP-1, hold your weekly injectable for one full week before the procedure, and restart once you are tolerating food afterward. A brief pause is a small price to pay for a safe procedure.

Sources

• ASA Guidance on GLP-1 Medications and Perioperative Management
• FDA Drug Safety Communication: GLP-1 Receptor Agonists and Aspiration Risk